{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:59:01Z","timestamp":1790776741526,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007537","name":"Freie Universitat Berlin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xphs.2026.104466","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:47:54Z","timestamp":1787122074000},"page":"104466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vitro feasibility studies for clinical microdialysis with lipophilic compounds: A case study with the antifungal posaconazole"],"prefix":"10.1016","volume":"115","author":[{"given":"Amrei-Pauline","family":"Konrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda Brita Sofia","family":"Aulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Mikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Kloft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.xphs.2026.104466_bib0001","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.48.5.1441-1453.2004","article-title":"Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue","volume":"48","author":"M\u00fcller","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104466_bib0002","first-page":"46","article-title":"Methods to measure target site penetration of antibiotics in critically ill patients","volume":"8","author":"Schwameis","year":"2013","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.xphs.2026.104466_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107085","article-title":"Breaking barriers: the novel in vitro microdialysis system enables reproducing in vivo extraction efficiencies of linezolid","volume":"209","author":"M\u00fcller","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2026.104466_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2005.01.017","article-title":"Microdialysis - theoretical background and recent implementation in applied life-sciences","volume":"25","author":"Plock","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104466_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejps.2018.10.030","article-title":"Drug combinations and impact of experimental conditions on relative recovery in in vitro microdialysis investigations","volume":"127","author":"Burau","year":"2019","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.xphs.2026.104466_bib0006","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ejps.2019.02.001","article-title":"High voriconazole target-site exposure after approved sequence dosing due to nonlinear pharmacokinetics assessed by long-term microdialysis","volume":"131","author":"Kirbs","year":"2019","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"10.1016\/j.xphs.2026.104466_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00077-23","article-title":"Model based estimation of posaconazole tablet and suspension bioavailability in hospitalized children using real-world therapeutic drug monitoring data in patients receiving intravenous and oral dosing","volume":"67","author":"Kane","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104466_bib0008","series-title":"Noxafil: EPAR - Product Information","author":"Merck","year":"2012"},{"issue":"7","key":"10.1016\/j.xphs.2026.104466_bib0009","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40265-020-01306-y","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole","volume":"80","author":"Chen","year":"2020","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.xphs.2026.104466_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01184-19","article-title":"Low Central nervous system posaconazole concentrations during cerebral phaeohyphomycosis","volume":"63","author":"Barde","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.xphs.2026.104466_bib0011","series-title":"Guideline M10 on Bioanalytical Method Validation and Study Sample Analysis","year":"2022"},{"issue":"2","key":"10.1016\/j.xphs.2026.104466_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.xphs.2026.104466_bib0013","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.R-project.org\/"},{"issue":"1","key":"10.1016\/j.xphs.2026.104466_bib0014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1208\/s12248-012-9412-z","article-title":"Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans","volume":"15","author":"Simmel","year":"2013","journal-title":"AAPS J"},{"issue":"4","key":"10.1016\/j.xphs.2026.104466_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060628","article-title":"Enhanced human tissue microdialysis using hydroxypropyl-\u00df-cyclodextrin as molecular carrier","volume":"8","author":"May","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.xphs.2026.104466_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98672-8","article-title":"Investigation of proteins important for microcirculation using in vivo microdialysis after glucose provocation: a proteomic study","volume":"11","author":"H\u00f6gstedt","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.xphs.2026.104466_bib0017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneumeth.2003.09.009","article-title":"Microdialysis of neuropeptide Y in human muscle tissue","volume":"132","author":"Ernberg","year":"2004","journal-title":"J Neurosci Methods"},{"issue":"4\u20135","key":"10.1016\/j.xphs.2026.104466_bib0018","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jpba.2008.02.025","article-title":"Microdialysis as a tool to determine free kidney levels of voriconazole in rodents: a model to study the technique feasibility for a moderately lipophilic drug","volume":"47","author":"Araujo","year":"2008","journal-title":"J Pharm Biomed Anal"},{"issue":"12","key":"10.1016\/j.xphs.2026.104466_bib0019","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s11095-022-03407-7","article-title":"Microdialysis of voriconazole and its N-oxide metabolite: amalgamating knowledge of distribution and metabolism processes in humans","volume":"39","author":"Schulz","year":"2022","journal-title":"Pharm Res"},{"issue":"S1","key":"10.1016\/j.xphs.2026.104466_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/2050-6511-13-S1-A74","article-title":"Characterization of colistin tissue pharmacokinetics by microdialysis","volume":"13","author":"Matzneller","year":"2012","journal-title":"BMC Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.xphs.2026.104466_bib0021","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jchromb.2009.11.017","article-title":"Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC\/MS\/MS","volume":"878","author":"Alffenaar","year":"2010","journal-title":"J Chromatogr B"},{"issue":"10","key":"10.1016\/j.xphs.2026.104466_bib0022","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/clinchem\/41.10.1522","article-title":"Composition of interstitial fluid","volume":"41","author":"Fogh-Andersen","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.xphs.2026.104466_bib0023","unstructured":"PubChem. Voriconazole. Accessed 16 September 2025. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/71616"},{"issue":"11","key":"10.1016\/j.xphs.2026.104466_bib0024","doi-asserted-by":"crossref","first-page":"695","DOI":"10.5414\/CPP48695","article-title":"Microdialysis feasibility investigations with the non-hydrophilic antifungal voriconazole for potential applications in nonclinical and clinical settings","volume":"48","author":"Simmel","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.xphs.2026.104466_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jpba.2011.01.005","article-title":"Unifying the mathematical modeling of in vivo and in vitro microdialysis","volume":"55","author":"Bungay","year":"2011","journal-title":"J Pharm Biomed Anal"},{"issue":"5","key":"10.1016\/j.xphs.2026.104466_bib0026","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1208\/s12248-017-0108-2","article-title":"Microdialysis as an important technique in systems pharmacology\u2014a historical and methodological review","volume":"19","author":"Hammarlund-Udenaes","year":"2017","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2026.104466_bib0027","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jneumeth.2012.06.010","article-title":"Approach to reduce the non-specific binding in microdialysis","volume":"209","author":"Nirogi","year":"2012","journal-title":"J Neurosci Methods"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926003163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:25:08Z","timestamp":1790774708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926003163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0022354926003163"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104466","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro feasibility studies for clinical microdialysis with lipophilic compounds: A case study with the antifungal posaconazole","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104466","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}],"article-number":"104466"}}